BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25174325)

  • 1. The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.
    Resnick MJ; Barocas DA; Morgans AK; Phillips SE; Koyama T; Albertsen PC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hoffman KE; Hoffman RM; Kaplan SH; McCollum D; Paddock LE; Stanford JL; Stroup AM; Wu XC; Penson DF
    Eur Urol; 2015 Jun; 67(6):1019-1025. PubMed ID: 25174325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results.
    Tyson MD; Koyama T; Lee D; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen V; Conwill R; McCollum D; Penson DF; Barocas DA
    Eur Urol; 2018 Jul; 74(1):26-33. PubMed ID: 29501451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment.
    Resnick MJ; Barocas DA; Morgans AK; Phillips SE; Chen VW; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hoffman KE; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Koyama T; Penson DF
    Cancer; 2014 Apr; 120(8):1263-71. PubMed ID: 24510400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study.
    Corsini C; Bergengren O; Carlsson S; Garmo H; Hjelm-Eriksson M; Fransson P; Kindblom J; Robinson D; Westerberg M; Stattin P; Carlsson SV
    Eur Urol Oncol; 2024 Jun; 7(3):605-613. PubMed ID: 38233329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: The evolution of self-reported urinary and sexual dysfunction over the last two decades: implications for comparative effectiveness research.
    Seftel AD
    J Urol; 2015 Apr; 193(4):1325. PubMed ID: 25890545
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term functional outcomes after treatment for localized prostate cancer.
    Resnick MJ; Koyama T; Fan KH; Albertsen PC; Goodman M; Hamilton AS; Hoffman RM; Potosky AL; Stanford JL; Stroup AM; Van Horn RL; Penson DF
    N Engl J Med; 2013 Jan; 368(5):436-45. PubMed ID: 23363497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.
    Tyson MD; Alvarez J; Koyama T; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen VW; Penson DF; Barocas DA
    Eur Urol; 2017 Aug; 72(2):307-314. PubMed ID: 27816300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.
    Stanford JL; Feng Z; Hamilton AS; Gilliland FD; Stephenson RA; Eley JW; Albertsen PC; Harlan LC; Potosky AL
    JAMA; 2000 Jan; 283(3):354-60. PubMed ID: 10647798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Nerve Sparing Status on Sexual and Urinary Function: 3-Year Results from the CEASAR Study.
    Avulova S; Zhao Z; Lee D; Huang LC; Koyama T; Hoffman KE; Conwill RM; Wu XC; Chen V; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Resnick MJ; Penson DF; Barocas DA
    J Urol; 2018 May; 199(5):1202-1209. PubMed ID: 29253578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study.
    Talcott JA; Rieker P; Clark JA; Propert KJ; Weeks JC; Beard CJ; Wishnow KI; Kaplan I; Loughlin KR; Richie JP; Kantoff PW
    J Clin Oncol; 1998 Jan; 16(1):275-83. PubMed ID: 9440753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical prostatectomy versus deferred treatment for localised prostate cancer.
    Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial.
    Haglind E; Carlsson S; Stranne J; Wallerstedt A; Wilderäng U; Thorsteinsdottir T; Lagerkvist M; Damber JE; Bjartell A; Hugosson J; Wiklund P; Steineck G;
    Eur Urol; 2015 Aug; 68(2):216-25. PubMed ID: 25770484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes.
    Huelster HL; Laviana AA; Joyce DD; Huang LC; Zhao Z; Koyama T; Hoffman KE; Conwill R; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg M; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
    Urol Oncol; 2020 Dec; 38(12):930.e23-930.e32. PubMed ID: 32736934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study.
    Vernooij RWM; Cremers RGHM; Jansen H; Somford DM; Kiemeney LA; van Andel G; Wijsman BP; Busstra MB; van Moorselaar RJA; Wijnen EM; Pos FJ; Hulshof MCCM; Hamberg P; van den Berkmortel F; Hulsbergen-van de Kaa CA; van Leenders GJLH; Fütterer JJ; van Oort IM; Aben KKH
    Urol Oncol; 2020 Sep; 38(9):735.e17-735.e25. PubMed ID: 32680820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study.
    Nam RK; Cheung P; Herschorn S; Saskin R; Su J; Klotz LH; Chang M; Kulkarni GS; Lee Y; Kodama RT; Narod SA
    Lancet Oncol; 2014 Feb; 15(2):223-31. PubMed ID: 24440474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course and predictors of symptoms after primary prostate cancer therapy.
    Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
    J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.
    Potosky AL; Legler J; Albertsen PC; Stanford JL; Gilliland FD; Hamilton AS; Eley JW; Stephenson RA; Harlan LC
    J Natl Cancer Inst; 2000 Oct; 92(19):1582-92. PubMed ID: 11018094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving Quality Assurance of Prostate Cancer Surgery During Reorganisation of Cancer Services.
    Cathcart P; Sridhara A; Ramachandran N; Briggs T; Nathan S; Kelly J
    Eur Urol; 2015 Jul; 68(1):22-9. PubMed ID: 25770482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study.
    Penson DF; McLerran D; Feng Z; Li L; Albertsen PC; Gilliland FD; Hamilton A; Hoffman RM; Stephenson RA; Potosky AL; Stanford JL
    J Urol; 2005 May; 173(5):1701-5. PubMed ID: 15821561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
    Hedgepeth RC; Labo J; Zhang L; Wood DP
    J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.